Skip to main content

Table 3 Symptoms and clinical features of the febrile patients, Northeastern Kenya

From: Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever

Variable

Total No. (n = 707)

Positive for Q fevera (%) (n = 116)

Crude OR (95%CI)

P- value

Headache

630

104 (16.5)

1.07 (0.56–2.05)

0.836

Chills

388

64 (16.5)

1.04 (0.68–1.51)

0. 945

Arthralgia/Myalgia

541

87 (16.1)

0.91 (0.57–1.44)

0.673

Malaise/Fatigue

493

87 (17.6)

1.37 (0.87–2. 15)

0.178

Anorexia

404

62 (15.3)

0.84 (0.56–1.25)

0. 380

ALRI

200

61 (30.5)

3.61 (2.39–5.44)

<0.001

Constipation

129

28 (21.7)

1.54 (0.96–2.48)

0.074

Night Sweats

94

12 (12.8)

0.71 (0.38–1.36)

0.308

Diarrhoea

73

8 (11.0)

0.60 (0.28–1.29)

0.081

Weight loss

62

11 (17.7)

1.11 (0.56–2.20)

0.765

Confusion

15

1 (6.6 %)

0.31 (0.01–7.09)

0.801

Rash

28

6 (21.4)

1.41 (0.56–3.56)

0.466

Vomiting

13

1 (7.7)

0.42 (0.05–3.23)

0.401

Abdominal pain

173

37 (21.4)

1.57 (1.01–2.42)

0.043

Palpable spleen

91

18 (19.8)

1.31 (0.56–8.69)

0.640

Palpable liver

38

5 (13.1)

0.78 (0.34–1.47)

0.486

Fever onset (>14 days)

253

108 (42.7)

41.52 (19.78–87.22)

<0.001

Age (>18 years)

618

106 (17.2)

1.64 (0.82–3.26)

0.162

Mean (SD)

Age (years)

707

33.6 ± 12.2

Fever onset (days)

707

14.5 ± 10.6

  1. ALRI acute lower respiratory infection, OR odds ratio, CI 95 % confidence interval, SD standard deviation
  2. aPatients meeting case definition for acute Q fever by serology or Coxiella DNA detection by qPCR
  3. Bolded variables were considered significant (P < 0.20) and fitted into multivariate logistic regression model